<?xml version="1.0" encoding="UTF-8"?>
<results title="virus">
 <result pre="exhibited broad-spectrum inhibitory activities against different types of viruses, including" exact="human immunodeficiency virus" post="(HIV), and hepatitis C virus (HCV) [66]. Compound 66"/>
 <result pre="obvious antivirus activity with 50% inhibition at 50Â Î¼M against" exact="dengue virus" post="serotype 2 productions by standard plaque assay, equivalent to"/>
 <result pre="same concentration, showing the potential for further development as a" exact="dengue virus" post="inhibitor [77]. Fig.Â 16 Chemical structure of compound 75"/>
 <result pre="developmentFront. Immunol.102019167531402910 69FeldmanS.A.HendryR.M.BeelerJ.A.Identification of a linear heparin binding domain for" exact="human respiratory syncytial virus" post="attachment glycoprotein GJ.Â Virol.7319996610661710400758 70YuM.GuanF.CaoF.JiaY.WangC.AÂ new antiviral pregnane from"/>
 <result pre="spNat. Prod. Res.3120171640164628278631 72LiangZ.MaoQ.GaoF.WangJ.Progress on the research and development of" exact="human enterovirus" post="71 (EV71) vaccinesFront. Med.7201311112123247645 73WuK.X.NgM.M.ChuJ.J.H.Developments towards antiviral therapies against"/>
</results>
